Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1998-5-29
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0149-5992
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
464-5
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:9540039-Adult,
pubmed-meshheading:9540039-Aged,
pubmed-meshheading:9540039-Aged, 80 and over,
pubmed-meshheading:9540039-Cohort Studies,
pubmed-meshheading:9540039-Cost-Benefit Analysis,
pubmed-meshheading:9540039-Diabetes Mellitus, Type 2,
pubmed-meshheading:9540039-Humans,
pubmed-meshheading:9540039-Hyperglycemia,
pubmed-meshheading:9540039-Middle Aged
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Cost-effectiveness of treatment of type 2 diabetes.
|
| pubmed:publicationType |
Letter
|